Health Technology
Egyptian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Macro Group Pharmaceutical S.A.E. dominates trading volume, whereas Sabaa International Company for Pharmaceutial and Chemical Industry logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
| 17.19 B EGP | 102.60 EGP | +0.72% | 588.96 K | 0.88 | — | — | — | 3.44% | Neutral | |
| 13.9 B EGP | 281.00 EGP | +1.08% | 469.44 K | 0.88 | 45.14 | 6.23 EGP | +17.60% | 0.72% | No rating | |
| 11.14 B EGP | 5.50 EGP | +0.36% | 8.38 M | 1.47 | 32.47 | 0.17 EGP | +38.40% | 0.55% | Neutral | |
| 9 B EGP | 793.85 EGP | −0.63% | 452 | 0.14 | — | — | — | 0.31% | No rating | |
| 8.98 B EGP | 601.50 EGP | +0.06% | 5.82 K | 0.71 | 16.26 | 37.00 EGP | +24.52% | 2.78% | No rating | |
| 7.11 B EGP | 317.00 EGP | +1.40% | 429.21 K | 1.24 | 13.91 | 22.78 EGP | +26.55% | 4.22% | No rating | |
| 6.6 B EGP | 1,335.01 EGP | +0.53% | 2.88 K | 0.79 | — | — | — | 4.77% | No rating | |
| 4.51 B EGP | 1.34 EGP | +1.52% | 36.09 M | 1.14 | — | — | — | 0.00% | No rating | |
| 4.49 B EGP | 187.21 EGP | +0.13% | 53 K | 2.58 | — | — | — | 0.00% | No rating | |
| 3.08 B EGP | 260.00 EGP | +1.39% | 9.83 K | 1.07 | 13.43 | 19.37 EGP | +16.81% | 3.25% | No rating | |
| 1.17 B EGP | 5.08 EGP | +8.78% | 19.29 M | 3.08 | — | −0.01 EGP | +82.95% | 0.00% | No rating |